These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6171994)

  • 1. Structure and antigenic behaviour of kappa I-immunoglobulin light-chain amyloid proteins.
    Westermark P; Sletten K; Natvig JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):199-203. PubMed ID: 6171994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further structural and antigenic studies of light-chain amyloid proteins.
    Natvig JB; Westermark P; Sletten K; Husby G; Michaelsen T
    Scand J Immunol; 1981 Jul; 14(1):89-94. PubMed ID: 6797050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid typing using antisera to prototype fibril proteins. A brief note.
    Linke RP
    Mech Ageing Dev; 1980; 14(1-2):187-90. PubMed ID: 6782378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
    Block PJ; Skinner M; Benson MD; Cohen AS
    Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
    Olsen KE; Sandgren O; Sletten K; Westermark P
    Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
    Solomon A; Frangione B; Franklin EC
    J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a kappa amyloid fibril protein.
    Gertz MA; Skinner M; Cohen AS; Connors LH; Kyle RA
    Scand J Immunol; 1985 Sep; 22(3):245-50. PubMed ID: 2864740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.
    Husby G
    Scand J Rheumatol; 1980; 9(1):60-4. PubMed ID: 6769151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of different amyloids with immunological techniques.
    Chastonay P; Hurlimann J
    Pathol Res Pract; 1986 Dec; 181(6):657-63. PubMed ID: 3104892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
    Cohen D; Pras M; Franklin EC; Frangione B
    Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and immunohistochemical study of familial amyloid polyneuropathy.
    Shoji S; Kameko M; Tsukada N; Kato M
    Neurology; 1981 Nov; 31(11):1493-6. PubMed ID: 6171755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
    Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
    Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue.
    Linke RP; Heilmann KL; Nathrath WB; Eulitz M
    Lab Invest; 1983 Jun; 48(6):698-704. PubMed ID: 6406764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
    Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
    J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.